EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Impact of bridging thrombolysis versus endovascular thrombectomy alone on outcomes in anticoagulated patients with atrial fibrillation and acute ischaemic stroke

Muath Alobaida iD, Stephanie L Harrison iD, Deirdre A Lane iD, Fiona Rowe iD, Philip Austin, Azmil H Abdul-Rahim iD, Gregory Y H Lip

European Journal of Neurology · 2024

DOI: 10.1111/ene.16453 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Neurology, 2024. Verfasst von Muath Alobaida und 6 weiteren Autor:innen. Beteiligte Einrichtung: Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverp…. Hauptthemen laut MEDLINE: Ischemic Stroke, Endovascular Procedures, Atrial Fibrillation, Anticoagulants. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and purpose The impact of bridging thrombolysis prior to endovascular thrombectomy (EVT) compared to EVT alone on intracerebral haemorrhage (ICH), subarachnoid haemorrhage (SAH), and death in anticoagulated atrial fibrillation (AF) patients with acute ischaemic stroke (AIS) is not well defined.

Methods

A retrospective study was conducted using data from a federated research network (TriNetX) including 114 health care organisations in the United States. Anticoagulated AF patients with AIS who received either bridging thrombolysis (BT) or EVT alone from September 2018 to November 2023 were included. Following propensity score matching, Cox regression analyses examined the risk of ICH, SAH, and death within 30 and 90 days, comparing anticoagulated AF patients receiving BT versus EVT only.

Results

A total of 3156 patients with AIS were treated with BT or EVT alone. Following 1:1 propensity score matching, the cohort included 766 patients in each group. ICH occurred within 30 and 90 days in 6.9% and 8.0% in the BT group compared with 7.4% and 7.7% in the EVT‐only group (hazard ratios [HR] = 0.92, 95% confidence interval [CI] = 0.63–1.33 and HR = 1.01, 95% CI = 0.71–1.45, respectively). SAH occurred within 30 and 90 days in 4.2% and 4.4% of patients in the BT compared to 3.0% and 3.4% in the EVT‐only group (HR = 1.38, 95% CI = 0.81–2.38 and HR = 1.29, 95% CI = 0.77–2.14, respectively). Death occurred within 30 and 90 days in 17.8% and 19.8% of patients in the BT compared to 22.2% and 27.3% in the EVT‐only group (HR = 0.77, 95% CI = 0.62–0.97 and HR = 0.65, 95% CI = 0.56–0.86, respectively).

Conclusions

In anticoagulated AF patients with AIS, BT was associated with a significantly lower risk of death, with no difference in ICH or SAH risk within 30 and 90 days compared to EVT only.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeEndovascular ProceduresAtrial FibrillationAnticoagulantsThrombolytic TherapyThrombectomyHumansMaleFemaleAgedRetrospective StudiesAged, 80 and overMiddle AgedTreatment OutcomeCerebral HemorrhageSubarachnoid Hemorrhage

Stichwörter der Autor:innen

anticoagulationatrial fibrillationbridging thrombolysisendovascular thrombectomyischaemic strokeoutcome

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart & Chest Hospital, Liverpool, UK.
  • Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
  • Department of Basic Science, Prince Sultan Bin Abdulaziz College for Emergency Medical Services, King Saud University, Riyadh, Saudi Arabia.
  • Registry of Senior Australians, South Australian Health and Medical Research Institute, Adelaide, Australia.
  • Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Institute of Population Health, University of Liverpool, Liverpool, UK.

ORCID-Profile: Muath Alobaida, Stephanie L Harrison, Deirdre A Lane, Fiona Rowe, Azmil H Abdul-Rahim

Zitieren

APA

Alobaida, M., Harrison, S. L., Lane, D. A., Rowe, F., Austin, P., Abdul-Rahim, A. H., & Lip, G. Y. H. (2024). Impact of bridging thrombolysis versus endovascular thrombectomy alone on outcomes in anticoagulated patients with atrial fibrillation and acute ischaemic stroke. European Journal of Neurology. https://doi.org/10.1111/ene.16453

Vancouver

Alobaida M, Harrison SL, Lane DA, Rowe F, Austin P, Abdul-Rahim AH, et al. Impact of bridging thrombolysis versus endovascular thrombectomy alone on outcomes in anticoagulated patients with atrial fibrillation and acute ischaemic stroke. European Journal of Neurology. 2024. doi:10.1111/ene.16453

BibTeX
@article{Alobaida2024,
  author = {Alobaida, Muath and Harrison, Stephanie L and Lane, Deirdre A and Rowe, Fiona and Austin, Philip and Abdul-Rahim, Azmil H and Lip, Gregory Y H},
  title = {Impact of bridging thrombolysis versus endovascular thrombectomy alone on outcomes in anticoagulated patients with atrial fibrillation and acute ischaemic stroke},
  journal = {European Journal of Neurology},
  year = {2024},
  doi = {10.1111/ene.16453}
}
Kostenlos starten →